¡Nos trasladamos! E-Prints cerrará el 7 de junio.

En las próximas semanas vamos a migrar nuestro repositorio a una nueva plataforma con muchas funcionalidades nuevas. En esta migración las fechas clave del proceso son las siguientes:

Es muy importante que cualquier depósito se realice en E-Prints Complutense antes del 7 de junio. En caso de urgencia para realizar un depósito, se puede comunicar a docta@ucm.es.

Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement



Downloads per month over past year

De Luca, Daniele and Foligno, Silvia and Autilio, Chiara and Vivanti, Alexandre and Vandekerckhove, Melanie and Martinovic, Jelena and Raschetti, Roberto and Guillot, Löic and Touqui, Lhoussaine (2022) Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement. American Journal of Physiology - Lung Cellular and Molecular Physiology, 323 (2). L121-L128. ISSN 1040-0605, Electronic: 1522-1504

[thumbnail of De Lucca, D. et al. 2022. Secretory phospholipase A2 expression and activity in preterm....pdf] PDF
Restringido a Repository staff only


Official URL: https://doi.org/10.1152/ajplung.00516.2021


Secretory phospholipase A2 (sPLA2) regulates the first step of inflammatory cascade and is involved in several pathological processes. sPLA2 also plays a role in preterm labor and parturition, since they are triggered by inflammatory mediators such as prostaglandins. Interestingly, chorioamnionitis (i.e., the presence of intrauterine inflammation) is also often associated with preterm birth. We aimed to verify if chorioamnionitis with fetal involvement modifies sPLA2 activity and expression profile in mothers and neonates delivered prematurely. We collected maternal plasma and amniotic fluid, as well as bronchoalveolar lavage fluid from preterm neonates born to mothers with or without clinical chorioamnionitis with fetal involvement. We measured concentrations of sPLA2 subtype-IIA and -IB, total enzyme activity, and proteins. Urea ratio was used to obtain epithelial lining fluid concentrations. Enzyme activity measured in maternal plasma (P < 0.001) and amniotic fluid (P < 0.001) was higher in chorioamnionitis cases than in controls. This was mainly due to the increased production of sPLA2-IIA, as the subtype -IB was present in a smaller amount and was similar between the two groups; sPLA2-IIA was increased in epithelial lining fluid (P = 0.045) or increased, although without statistical significance, in maternal plasma (P = 0.06) and amniotic fluid (P = 0.08) of chorioamnionitis cases. Cytokines that are known to increase sPLA2-IIA expression (TNF-a and IL-1b) or whose expression was increased by sPLA2-IIA (IL-8) were higher in histologically confirmed chorioamnionitis [TNF-a (P = 0.028), IL-1b (P < 0.001), and IL-8 (P = 0.038)]. These data represent the basis for future studies on sPLA2-IIA inhibition to prevent deleterious consequences of chorioamnionitis and preterm birth.

Item Type:Article
Uncontrolled Keywords:Chorioamnionitis; Mother; Neonate; Prematurity; surfactant
Subjects:Medical sciences > Medicine > Biochemistry
Medical sciences > Medicine > Pneumology
ID Code:75090
Deposited On:14 Oct 2022 10:57
Last Modified:14 Oct 2022 12:06

Origin of downloads

Repository Staff Only: item control page